Category Archives: Myeloma Prognosis & Outcomes

Supportive treatments

Addition of doxycycline to ciprofloxacin for infection prophylaxis during autologous stem cell transplants for multiple myeloma. Sivik JM et al. Support Care Cancer. 2018 Mar 21. doi: 10.1007/s00520-018-4165-6. [Epub ahead of print]. Evaluation of the relevance of surgery in patients with multiple myeloma harboring symptomatic spinal involvement: a retrospective case series. Quidet M et al. World Neurosurg. 2018 Mar 9. pii: S1878-8750(18)30458-3. doi: 10.1016/j.wneu.2018.02.184.…

Supportive treatments

Denosumab for myeloma bone disease: ready for prime time? Dimopoulos MA et al. Lancet Oncol. 2018 Feb 8. pii: S1470-2045(18)30075-5. doi: 10.1016/S1470-2045(18)30075-5. [Epub ahead of print]. Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study. Raje N et al. Lancet Oncol. 2018 Feb 8. pii: S1470-2045(18)30072-X. doi: 10.1016/S1470-2045(18)30072-X. [Epub ahead of…

Supportive treatments

Orchestration of Chemomobilization and G-CSF Administration for Successful Hematopoietic Stem Cell Collection. Kriegsmann K et al. Biol Blood Marrow Transplant. 2018 Jan 15. pii: S1083-8791(18)30022-3. doi: 10.1016/j.bbmt.2018.01.007. [Epub ahead of print]. Role of Bone-Modifying Agents in Multiple Myeloma: American Society of Clinical Oncology Clinical Practice Guideline Update. Anderson K et al. J Clin Oncol. 2018 Jan 17:JCO2017766402. doi: 10.1200/JCO.2017.76.6402. [Epub ahead of…

Supportive treatments

Mobilization of Hematopoietic Progenitor Cells with Standard or Reduced Dose Filgrastim after Vinorelbine in Multiple Myeloma Patients. a Randomized Prospective Single Center Phase II Study. Samaras P et al. Biol Blood Marrow Transplant. 2017 Dec 12. pii: S1083-8791(17)31679-8. doi: 10.1016/j.bbmt.2017.12.775. [Epub ahead of print]. Prevention and management of adverse events of Novel agents in multiple myeloma: A consensus of the european myeloma network.…

Supportive treatments

New agents in the Treatment of Myeloma Bone Disease.
Ring ES et al. Calcif Tissue Int. 2017 Nov 2. doi: 10.1007/s00223-017-0351-7. [Epub ahead of print].

Ciprofloxacin versus Levofloxacin for prophylaxis during Hematopoietic Stem Cell Transplantation.
Copeland V et al. Clin Transplant. 2017 Oct 28. doi: 10.1111/ctr.13145. [Epub ahead of print].

Supportive treatments

Advances in the Treatment of Paraproteinemic Neuropathy. Nobile-Orazio E et al. Curr Treat Options Neurol. 2017 Oct 16;19(12):43. doi: 10.1007/s11940-017-0479-9. Effectiveness of IHD with Adsorptive PMMA Membrane in Myeloma Cast Nephropathy: A Cohort Study. Sens F et al. Am J Nephrol. 2017 Oct 10;46(5):355-363. doi: 10.1159/000481461. [Epub ahead of print]. Interbody distraction and vertebral body reconstruction with polymethylmethacrylate for the treatment of pathological…

Supportive treatments

Oncological and functional results of the surgical treatment of vertebral metastases in patients with multiple myeloma. Guzik G et al. BMC Surg. 2017 Aug 23;17(1):92. doi: 10.1186/s12893-017-0288-9. Kidney Transplantation in Patients With Active Multiple Myeloma: Case Reports. Lum EL et al. Transplant Direct. 2017 Jul 21;3(8):e200. doi: 10.1097/TXD.0000000000000716. eCollection 2017 Aug. Bisphosphonate guidelines for treatment and prevention of myeloma bone disease. Lee OL et al. Intern Med…

Supportive treatments

The Role of Low-dose Anti-thymocyte Globulin as Standard Prophylaxis in Mismatched and Matched Unrelated Hematopoietic Peripheral Stem Cell Transplantation for Hematologic Malignancies. Sakellari I et al. Clin Lymphoma Myeloma Leuk. 2017 Jun 29. pii: S2152-2650(17)30096-4. doi: 10.1016/j.clml.2017.06.008. [Epub ahead of print]. Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide as Graft-Versus-Host Disease Prophylaxis in Multiple Myeloma. Ghosh N et al. Biol Blood Marrow…

Supportive treatments

Comparison of the CELLEX™ and UVAR-XTS™ closed-system extracorporeal photopheresis devices in the treatment of chronic graft-versus-host disease. Whittle RM et al. J Clin Apher. 2017 Jun 13. doi: 10.1002/jca.21541. [Epub ahead of print]. Comparison of Operative Time with Conventional Fluoroscopy versus Spinal Neuronavigation in Instrumented Spinal Tumor Surgery. Miller JA et al. World Neurosurg. 2017 Jun 9. pii: S1878-8750(17)30908-7. doi: 10.1016/j.wneu.2017.06.016.…

Supportive treatments

Variability of high-dose melphalan exposure on oral mucositis in patients undergoing prophylactic low-level laser therapy.
Rodrigues GH et al. Lasers Med Sci. 2017 May 16. doi: 10.1007/s10103-017-2211-0. [Epub ahead of print].

G-CSF improves safety when you start the day after autologous transplant in multiple myeloma.
Sborov DW et al. Leuk Lymphoma. 2017 May 16:1-5. doi: 10.1080/10428194.2017.1318436. [Epub ahead of print].